Biomarkers, inflammation and cancer: where to go?

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F16%3A33160401" target="_blank" >RIV/61989592:15110/16:33160401 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1515/cclm-2016-0769" target="_blank" >http://dx.doi.org/10.1515/cclm-2016-0769</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1515/cclm-2016-0769" target="_blank" >10.1515/cclm-2016-0769</a>

Result language
angličtina
Original language name
Biomarkers, inflammation and cancer: where to go?
Original language description
Laboratory medicine plays an important role in the management of cancer patients. The success in the tratment of cancer is critically dependent on the collaboration of the multidisciplinary team that obviously includes also specialists in clinical chemistry and laboratory medicine. Information from the laboratory has far-reachnig consequences that help in guiding the management of the patient from the moments preceding the diagnosis throughout the multidisciplinaty therapy to subsequent follow-up or palliative care, and is crucial for the diagnosis, prediction of response and prognosis, monitoring of tratment effect, or detection of toxicity.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)